Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What do you think of Tang getting involved? Although this guy has a spotty record (insider trading), I don't think he'd invest without a pretty high ROI expectation.
R/S is a distinct possibility here. Lazard has probably recommended this as one of the strategic options. I'll go out on a limb and postulate that they may not do so until after they see the results of the May FDA PDUFA. If at that time the share price goes back above $1.00 (which I believe is likely)then they have some breathing room and may reconsider R/S at least temporarily. I really got burned on the EFTC R/S so hope they do not pursue R/S. I'm guessing any R/S would be around 5:1. I've got a significant amount invested in this at 1.05 (having brought my average down with some 0.50 buys)and at this point would be glad to make that back. I'm still thinking the FDA approval probability is >65%.
Bought more today at 0.51. Will definitely bring my average cost down.....Think we'll hover around these prices till April. Barring any reverse stock split...or,...
Wish I had your starting position. Unless this fails FDA I think there is little down side left. I think I absorbed most of it! LOL!
I think it's a good move for you. I plan on increasing my position tomorrow. Wish this had been my average cost. From my standpoint (assuming FDA approval) the current position just means I'll have to wait longer to recover my losses to this point.
If you anticipate FDA approval (I give it >60% chance)I believe it is time to increase your position here. I have to wait till Tuesday to move some funds around but, am going to increase my position then. Sure wish I could have gotten in at 0.45.
I'm betting (not investing at this point mind you, it's gone way beyond that point)approval chances >60%. If FDA approves, Europe is probably not far behind (they had basically the same issues as FDA). Wish I could tell you odds were better than that but, this stock has been nothing but a surprise on the down side.
Don't worry, when they do a reverse stock split your shares will be worth 10 times as much! LOL
LOL. My "spidey sense" was tingling yesterday ...I should have listened. I still like the technology...the company...not so much. I'll probably buy more in the next few days in the 0.50 range. This stock is definitely not for the weak of heart. In my case however, it may be for the weak of intellect.
I believe from the company standpoint this is the smart thing to do. I'm assuming that this is what Lazard recommended they do. First, it lets the company have cash available to get through FDA approval. And it probably gives them time (assuming approval) to shop around for the best deal without having to rush or sell low after approval. I hate the fact that the price per share will now (most likely) be in the sub-0.60 range and we'll all have a significantly longer wait to realize any significant return. On the other hand since I'm in this deep I'm probably buying at 0.50.
Bought more at 0.66 today. May buy a bit more in the lower 0.60s range if/when it gets there. I don't see the European questions/concerns as much different from the FDA's. Sure wish my average cost was closer to this price. If this makes it through FDA (I give it >60% probability) I think the applications for this device are going to be be numerous and in quick succession.
"On January 31, 2012, Alexza Pharmaceuticals, Inc. ("Alexza") received a notice (the "Notice") from The Nasdaq Stock Market ("NASDAQ") indicating that Alexza's common stock (the "Common Stock")...blah...blah..
Under NASDAQ Rule 5810(c)(3)(A), Alexza has a 180 calendar day grace period from the date of the Notice to regain compliance by meeting the continued listing standard."
So, bottom line is they have until approximately the end of July to get back above $1.00. With approval in May I think this will happen. That would negate the need for reverse split (which BTW I got killed on for ETFC). Without approval this company would be headed to bankruptcy. I believe, based on the panel approval and revised REMS, they will get approval.
If patient dosing has occurred or occurs shortly I suspect some word regarding results will (inevitably) leak out at about the 12-15 week mark. The results to-date behind this look pretty decent, our brothers from Down Under are generally pretty conservative scientifically and I believe the study participants are "A-List". I think my path ahead will be to buy relatively small amounts in the dips till the late April-May-June 2012 timeframe and at that point keep a close watch for a creep up in volume. Just thinking out loud...
No "real" information on layoffs, just the usual rumors. If I were the CEO I'm not sure if I'd conserve remaining $ by laying off non-essential employees. I'd (personally) probably ask them to take as much leave as they could to get us (the Company) through the PDUFA while at the same time lining up something to quickly get some cash in the event of FDA approval. Given the very public pre-layoff notification, and PDUFA extension I'm surprised the stock hasn't taken a bigger hit. It should be an interesting couple of months (wild swings). I'm holding back a bit of cash to buy some in the $0.60 range if it gets back there.
I bought a little bit more last week. Expect there will be a few more lows I can buy in to but, these statements ("gym gravity" post)look like a semi-almost-sort-of marketing by the company. I'll take it.
Wonder how many got lay-off notices and if they will proceed with reduction in force due to the FDA extension? This ~$0.70 range is no fun.
No mention of PRAN/PBT but different take on iron causation.
http://online.wsj.com/article/SB10001424052970204740904577192901072611524.html
Shhhhh!....I'm hoping nobody catches on till I can afford more...
Once they get the first use of the staccato device approved it will open the door for many other drugs to be administered with this. As much as I hate to say it.....90 more days isn't too long to wait (he said impatiently).
May wait till tomorrow to see the level-off and buy more. Considering the news the I'm surprised the panic sale/loss over-reaction isn't more already.
Oh Oh...In a notice received from the FDA, the Prescription Drug User Fee Act (PDUFA) date for the ADASUVE NDA has been extended from February 4, 2012 to May 4, 2012.
Think I'll add a bit more (~5-10 K shares)as well if the price remains +/-0.05. GLTA
More of the same steady decline today. I've been buying in bits and pieces at the day lows (or what I thought were the lows). If it gets into the .65-.60 range in the next week I may plunge a little deeper (he said hesitatingly). I notice this board has been pretty quiet...anybody out there?
After all the drama surrounding this stock I'd like to at least make a little bit. In at $1.08.
Interesting turn around by Jason Napodano.
http://bionapcfa.blogspot.com/2011/12/twelve-biotechs-to-watch-in-2012.html?showComment=1324581333901#c889725320952538049